Pyrexia of Unknown Origin (28 March 2022)

Dr Anda Bularga discusses with Dr Meghan Perry, t…

An episode of the Clinical Conversations podcast, hosted by Royal College of Physicians of Edinburgh, titled "Pyrexia of Unknown Origin (28 March 2022)" was published on March 28, 2022 and runs 30 minutes.

March 28, 2022 ·30m · Clinical Conversations

0:00 / 0:00

Summary

Dr Anda Bularga discusses with Dr Meghan Perry, the variety and complexity of cases which present with pyrexia of unknown origin, and how experience, clinical skill and detective work contribute in this fascinating area of medicine. Recording date: 23 June 2021 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: [email protected]

Episode Description

Dr Anda Bularga discusses with Dr Meghan Perry, the variety and complexity of cases which present with pyrexia of unknown origin, and how experience, clinical skill and detective work contribute in this fascinating area of medicine. Recording date: 23 June 2021 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: [email protected]

Share this episode

Similar Episodes

Why Couples Stop Talking About Sex (And How to Start Again)

Mar 20, 2026 ·11m

Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School

Mar 17, 2026 ·62m

The Small Daily Habits That Hold a Marriage Together

Feb 19, 2026 ·8m

How to Fight Fair in Marriage: Arguing Without Destroying Your Connection

Feb 11, 2026 ·17m

Why Waiting to Feel "Emotionally Safe" Is Keeping Your Relationship Stuck

Jan 28, 2026 ·8m

Video Episode 68: Sinan Gölhan, CEO at GelTech Labs

Jan 27, 2026 ·44m

Similar Podcasts

Clinical Trial Podcast | Conversations with Clinical Research Experts Kunal Sampat | Educator Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career.You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals. To learn more, visit https://clinicaltrialpodcast.com/ Primary Care Today ReachMD Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care. Few & Far Between: How Biotech Gets Built Chris O'Brien Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul

URL copied to clipboard!